Home / Community / News / News

News

12/11/2017 - 2:06pm

Increased skin cancer risks in DM1 are captured in a new, longitudinal electronic medical records study.

12/11/2017 - 2:00pm

A recent publication suggests that a serum protein may ultimately have value as a biomarker for conduction system abnormalities in DM.

11/13/2017 - 11:36am

CRISPR is an exploratory strategy with potential for treatment of RNA-triggered diseases. Will DNA or RNA targeting prove to be the best approach for DM?

11/13/2017 - 11:25am

Genetic and epigenetic mechanisms drive differences between CDM and DM1—a new study elucidates downstream signaling pathways that underlie their diverse phenotypes and represent putative therapy development targets for CDM.

11/13/2017 - 11:19am

Age and gender impact the onset and progression of DM2, but the pattern shows both similarities and differences from that of DM1.

Partners

© Myotonic Dystrophy Foundation. All rights reserved.